Dr. Snyder's laboratory uses a variety of approaches to analyze genomes and regulatory networks.

Dr. Michael Schumacher is a gastrointestinal physiologist focused on discovering new therapeutic targets for inflammatory bowel disease (IBD) including ulcerative colitis and Crohn’s disease. Dr. Schumacher's lab studies how intestinal tissues interpret, respond to, and recover from inflammation, with a particular emphasis on how immune signals shape epithelial function, tissue remodeling, and mucosal healing.

The Angelo lab uses custom built high dimensional imaging technologies and computational approaches to understand the interplay between single cell phenotype and tissue histology in health and disease.

Dr. Marmor's group has studied the modification of retinal ischemic damage, laser action upon the RPE and drug effects upon retina and RPE. Recent collaborative work has been considering means of replacing Bruch's membrane or RPE in diseased eyes, and the development of a retinal prosthesis.